Precision Medicines and Companion Diagnostics...

  • DATE & TIME

    26 September 2017 - 27 September 2017
    09:00am - 06:00pm

  • PLACE

    Grand Copthorne Waterfront Hotel

  • Contact

    CoRE@duke-nus.edu.sg or +65 6601 5147

ABOUT THE EVENT

Precision Medicines and Companion Diagnostics Workshop

REGISTRATION IS NOW CLOSED. THANK YOU FOR YOUR OVERWHELMING SUPPORT.
   
As medical treatment embraces the concept of precision medicines with the hope of optimising health outcomes, many are seeking to understand this new movement and how it may impact the current landscape. In particular, devices designed to complement the new therapies are often overlooked, even though such companion diagnostics are critical to the success of the precision medicines. This 1.5 day workshop provides the opportunity to hear from regulatory experts from major regulatory authorities and the industry, and participate in discussions on how to facilitate the accessibility of these trending healthcare products.
          

10% discount for groups of 5 or more.
  
10% discount for CoRE Contributors.
  
All prices are inclusive of GST.
   
All prices in SGD.
    
REGISTRATION IS NOW CLOSED. THANK YOU FOR YOUR OVERWHELMING SUPPORT.

Speakers of the event

Dr. Debra Rasmussen

Senior Director
Global Regulatory Affairs
Diagnostics Leader
Janssen

Dr. Jorge Villacian

Chief Medical Officer
Janssen Diagnostics

 

Dr. Reiko Yanagihara

Deputy Review Director
Office of In Vitro Diagnostics
Pharmaceuticals & Medical Devices Agency (PMDA)
Japan

Associate Professor Sonia Davila

SingHealth Duke-NUS Institute of Precision Medicine (PRISM)
Adjunct Associate Professor
Duke-NUS Medical School
Honorary Senior Research Fellow
Faculty of Medicine
Imperial College London

 

Dr. Maria C. M. Orr

Executive Director
Personalised Healthcare and Biomarkers
AstraZeneca

Dr. Krishna Prasad

Group Manager
Senior Medical Assessor
UK Medicines and Healthcare products Regulatory Agency

 

Adjunct Assistant Professor Srinivasan Kellathur

Head
Advanced Therapy Product Unit
Health Sciences Authority

Dr. Janaki Veeraraghavan

Senior Staff Fellow
Division of Molecular Genetics & Pathology
US Food and Drug Administration